Literature DB >> 1690434

Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal; doses required, stereospecificity and actions of Bay K 8644.

J M Littleton1, H J Little, M A Whittington.   

Abstract

The effects of dihydropyridine calcium channel antagonists, and the calcium channel activator, Bay K 8644, were examined on the convulsive behaviour induced by handling in mice following withdrawal from chronic ethanol inhalation. Nimodipine and nitrendipine and PN 200-110 significantly decreased the convulsive behaviour, after intraperitoneal doses of the same order of magnitude as have been found by others to be required for displacement of radiolabelled dihydropyridine in the CNS. The (+) isomer of PN 200-110 was effective, but the (-) isomer, which is ineffective in vitro, had no significant action. Bay K 8644 prevented the actions of nimodipine against the ethanol withdrawal syndrome. The behavioural ratings after nimodipine plus Bay K 8644 were significantly higher than after vehicle treatment. Bay K 8644 alone, when given to naive mice, caused convulsive behaviour resembling that seen in withdrawal from chronic ethanol treatment, but when given during ethanol withdrawal did not significantly increase the behavioural signs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690434     DOI: 10.1007/bf02244612

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  Stereoselectivity at the calcium channel: different profiles of hemodynamic activity of the enantiomers of the dihydropyridine derivative PN 200-110.

Authors:  R P Hof; A Hof; U T Ruegg; N S Cook; A Vogel
Journal:  J Cardiovasc Pharmacol       Date:  1986 Mar-Apr       Impact factor: 3.105

2.  Are changes in neuronal calcium channels involved in ethanol tolerance?

Authors:  S J Dolin; H J Little
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

3.  Alcohol withdrawal reactions in mice: effects of drugs that modify neurotransmission.

Authors:  D B Goldstein
Journal:  J Pharmacol Exp Ther       Date:  1973-07       Impact factor: 4.030

4.  Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine.

Authors:  G P Dubé; Y H Baik; A Schwartz
Journal:  J Cardiovasc Pharmacol       Date:  1985 Mar-Apr       Impact factor: 3.105

5.  The behavioral effects of the calcium agonist Bay K 8644 in the mouse: antagonism by the calcium antagonist nifedipine.

Authors:  G T Bolger; B A Weissman; P Skolnick
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

6.  Calcium channel antagonists decrease the ethanol withdrawal syndrome.

Authors:  H J Little; S J Dolin; M J Halsey
Journal:  Life Sci       Date:  1986-12-01       Impact factor: 5.037

7.  Modulation of calcium ion influx by the 1,4-dihydropyridines nifedipine and BAY K 8644.

Authors:  M Schramm; R Towart; B Lamp; G Thomas
Journal:  J Cardiovasc Pharmacol       Date:  1985 May-Jun       Impact factor: 3.105

8.  Dihydropyridine calcium channel activators and antagonists influence depolarization-evoked inositol phospholipid hydrolysis in brain.

Authors:  D A Kendall; S R Nahorski
Journal:  Eur J Pharmacol       Date:  1985-09-10       Impact factor: 4.432

9.  Differential influence of the calcium antagonist nitrendipine and the vasodilator hydralazine on normal and elevated blood pressure.

Authors:  A Knorr; B Garthoff
Journal:  Arch Int Pharmacodyn Ther       Date:  1984-06

10.  Bay K 8644 induces a reversible spasticity-like syndrome in rats.

Authors:  E N Petersen
Journal:  Eur J Pharmacol       Date:  1986-11-04       Impact factor: 4.432

View more
  19 in total

1.  The effects of chronic treatment with the dihydropyridine, Bay K 8644, on hyperexcitability due to ethanol withdrawal, in vivo and in vitro.

Authors:  M A Whittington; A R Butterworth; S J Dolin; T L Patch; H J Little
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

2.  Ethanol tolerance and withdrawal severity in high drinking in the dark selectively bred mice.

Authors:  John C Crabbe; Alexandre M Colville; Lauren C Kruse; Andy J Cameron; Stephanie E Spence; Jason P Schlumbohm; Lawrence C Huang; Pamela Metten
Journal:  Alcohol Clin Exp Res       Date:  2012-02-06       Impact factor: 3.455

3.  Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine.

Authors:  M Barrios; J M Baeyens
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

5.  An examination of the anticonvulsant properties of voltage-sensitive calcium channel inhibitors in amygdala kindled seizures.

Authors:  C M Mack; M E Gilbert
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 6.  Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

Authors:  Patrycja Kleczkowska; Irena Smaga; Małgorzata Filip; Magdalena Bujalska-Zadrozny
Journal:  Neurotox Res       Date:  2016-08-02       Impact factor: 3.911

7.  Do GABAB receptors have a role in causing behavioural hyperexcitability, both during ethanol withdrawal and in naive mice?

Authors:  A J Mead; H J Little
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

Review 8.  From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.

Authors:  Zeeba D Kabir; Arlene Martínez-Rivera; Anjali M Rajadhyaksha
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

9.  Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.

Authors:  S Tokuyama; I K Ho
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

10.  Changes in intrinsic inhibition in isolated hippocampal slices during ethanol withdrawal; lack of correlation with withdrawal hyperexcitability.

Authors:  M A Whittington; H J Little; J D Lambert
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.